The FDA's Center for Drug Evaluation and Research conducts an analysis of the benefits and risks to ensure the vaccine meets the FDA's standards for approval.ĪCIP published their recommendation for use of the Moderna COVID-19 Vaccine.įDA issued the second EUA for use of the Moderna COVID-19 vaccine in persons aged 18 years and older for the prevention of COVID-19. When the FDA approves a vaccine, it must undergo the agency's standard approval process for reviewing the quality, safety and effectiveness. CDC RecommendationĪfter the FDA authorizes the emergency use of a vaccine, an independent panel of medical and health experts called the Advisory Committee on Immunization Practices (ACIP) provides recommendations and guidance to the Director of the Centers for Disease Control and Prevention (CDC) regarding the use of the vaccine. The FDA determines that these vaccines are safe and effective for public use. The FDA then issues Emergency Use Authorizations (EUAs) for certain vaccines that meet rigorous, science-based standards. The Food and Drug Administration (FDA) reviews and evaluates COVID-19 vaccines for quality, safety, and effectiveness. government established a coordinated strategy to prioritize the development of the most promising vaccines for the prevention of COVID-19. When the COVID-19 pandemic began, researchers were able to come up with vaccines for this new virus much faster because of work that was already happening.Īs part of the federal response to the Coronavirus pandemic, the U.S.
#TIMELINE OF VACCINES HOW TO#
Years before the COVID-19 pandemic, scientists were already studying coronaviruses to find out how to protect against them. Read the Secretary's directive on the Pfizer COVID-19 vaccine booster* (September 25, 2021)ĬOVID-19 Vaccine Development and Authorization.Read the Secretary's directive on the Moderna and Janssen (Johnson and Johnson) vaccine boosters* (October 22, 2021).Read the Secretary's directive on the availability of booster doses of COVID-19 vaccines (November 21, 2021).Read the Secretary's directive on booster doses of the Pfizer COVID-19 vaccine for adolescents ages 16 and 17* (December 10, 2021).The Secretary has issued directives to expand eligibility for COVID-19 vaccine boosters to all adults ages 18 and older and adolescents ages 16 and 17 who are already fully vaccinated. Read the joint letter from HHS Secretary Becerra and Education Secretary Cardona about how schools can support COVID-19 vaccination for children (November 8, 2021).Read the Secretary's directive on the Pfizer COVID-19 vaccine for children ages 5 through 11 (November 3, 2021).The Secretary has issued a directive to expand eligibility for children five years and older to receive an age-appropriate dose of the Pfizer COVID-19 vaccine. Vaccinations in the United States began on December 14, 2020.
The federal government has been working since the pandemic started to develop, manufacture, and distribute safe and effective COVID-19 vaccines.
0 kommentar(er)
